$ZDPY

Zoned Properties, Inc. (ZDPY): Results of Operations and Financial Condition

Zoned Properties, Inc. (ZDPY) filed an SEC Form 8-K — Results of Operations and Financial Condition. false 0001279620 0001279620 2026-08-14 2026-08-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report

Original reporting
Published Aug 14, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ZDPY
Neutral
low confidence
Mentioned
$ZDPY
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ZDPYNeutralLow
01

Why it matters

The filing indicates a new quarterly results release for the quarter ended June 30, 2026, which can affect near-term trading if the omitted Exhibit 99.1 contains beats/misses or changes in outlook.

02

Market read

Traders should treat this as a quarterly results release event, but the provided text lacks the figures needed to judge impact.

03

What to watch

The attached Exhibit 99.1 likely contains the actionable numbers and any guidance, but they are not present in the provided article text.

Relevance 7/10Novelty 3/10Timing: Filed Aug 14, 2026, after-hours (8-K filed 16:05 ET)

Background

The company filed SEC Form 8-K Item 2.02 to report results of operations and financial condition, referencing an attached press release (Exhibit 99.1).

Company-level read

Ticker impact

$ZDPYNeutralLow confidence
Context

Zoned Properties filed an 8-K stating it issued a press release with financial results for the quarter ended June 30, 2026.

Expected impact

Near-term volatility is possible on release day, but direction cannot be inferred from the provided text.

Evidence & confidence

The filing confirms results were released, yet the article body contains no numbers, outlook, or qualitative drivers to map to a specific valuation or risk change.

Market effects

No sector read-through is provided beyond a routine quarterly results disclosure.

None stated.

None stated.

Counterpoint

Because the scraped text omits the actual results, traders may already have the key datapoints elsewhere; this filing may be more administrative than decision-driving.

Key entities

  • Zoned Properties, Inc.

    Subject of the 8-K, issued a press release with quarterly financial results for the quarter ended June 30, 2026.

  • SEC Form 8-K

    Item 2.02 disclosure of results of operations and financial condition, filed Aug 14, 2026.

Related articles

$BKSYMed

BlackSky (BKSY) Q2 2026 Earnings Call Transcript

BlackSky (BKSY) discussed its Q2 2026 earnings call, citing Gen-3 satellite performance and Spectra AI platform. It reported Q2 total revenue up 50% year over year, adjusted EBITDA margin of 14% on $33 million revenue, and $200 million year-to-date bookings. The company raised $150 million, boosting liquidity above $325 million, and said Gen-3 related products drove 90% of growth.

$CRMDMed

CorMedix Q2 Earnings Call Highlights

CorMedix (NASDAQ:CRMD) reported Q2 revenue rising to $39.7M from $39.7M a year earlier, with 2026 including $66.1M DefenCath sales and $35.8M from the Melinta portfolio. Net income was $26.0M ($0.33 basic). It reaffirmed 2026 revenue guidance of $325M-$345M and raised adjusted EBITDA to $125M-$140M. REZZAYO supplemental NDA is planned for Q3 2026, with FDA action expected H1 2027.

$CLBTMed

Cellebrite (CLBT) Stock Rebounds As ARR Grows But Outlook Cools

Simply Wall St reports Cellebrite (CLBT) shares rose about 3% after results despite a prior 30% drop. Q2 revenue was US$131.1m (up from US$113.3m), while ARR was US$508m (up from US$420m). Management raised full-year adjusted EBITDA margin guidance to the high 20s but trimmed ARR outlook to US$550m to US$560m.

$CLXMed

Are Wall Street Analysts Predicting Clorox Stock Will Climb or Sink?

The article says The Clorox Company (CLX) shares have lagged the S&P 500 over 52 weeks, down 13.7% versus SPX up 20.6%. After Q4 2026 results on Aug. 3, CLX rose 6.5% on $1.95B sales and adjusted EPS $1.66, plus FY2027 net sales growth guidance of 13%-14%. Analysts: consensus Hold, JPMorgan raised PT to $95; stock trades above the mean $96.94, with a Street-high $117.

$CDNSMed

CDNS Falls 12.9% in the Past Month. Is the Sell-Off an Opportunity?

Cadence Design Systems (CDNS) shares fell 12.9% over the past month despite Q2 results. According to the company, Q2 revenue rose 24.2% to $1.584B and non-GAAP EPS rose 27.9% to $2.11. The company raised 2026 guidance to $6.26-$6.34B revenue and $8.05-$8.15 EPS, with backlog at a record $8.1B. Valuation remains at 36.3x forward earnings.

$AIRTMedAI 8/10

Air T, Inc. Continues Track Record of Growth in First Quarter Fiscal 2027: Crestone Completes Acquisition of Arena

Air T, Inc. (NASDAQ:AIRT) reported fiscal 2027 first-quarter results for the period ended June 30, 2026. Revenue rose to $115.5 million, up 63% year over year, while operating loss widened to $12.8 million. Adjusted EBITDA was $0.8 million, down 45%. The company said results were pressured by acquisition and integration costs tied to Crestone’s Arena deal and non-cash depreciation from purchase accounting. Crestone acquired Arena Aviation Capital for $33.9 million.